The burden of malignant melanoma--lessons to be learned from Austria

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Babak MonshiKlemens Rappersberger

Abstract

Incidence rates of melanoma, generated by cancer registries (CRs), are susceptible to reporting inconsistencies due to increasing decentralisation of diagnosis. We therefore independently assessed the burden of melanoma in Austria. We collected histopathological reports on melanoma of all patients diagnosed in Austria in 2011. Demographic and clinical characteristics, histopathological tumour stages were assessed. Their regional distributions and incidence rates were analysed and compared with data of national and international CRs. A total of 5246 patients were diagnosed with 1951 in-situ and 3295 invasive melanomas in Austria in 2011 (population 8.4 million). Age, sex and anatomic distribution corresponded to findings in other European countries, however, the incidence of 25/100,000 (world age-standardised rate) for invasive melanomas was two-fold higher than published by the Austrian CR (12/100,000). Varying frequencies in diagnosing thin melanomas (≤1 mm; n = 4415) accounted exclusively for significant regional disparities, while advanced tumours (>1 mm; n = 761) were evenly distributed. Western Austria showed the highest rates (36/100,000). Patients from eastern Austria whose melanomas were diagnosed in laboratories in wes...Continue Reading

References

Aug 6, 2005·BMJ : British Medical Journal·H Gilbert WelchLisa M Schwartz
Nov 22, 2008·Journal of the American Academy of Dermatology·Myles CockburnChristina A Clarke
Jan 2, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Freddie Bray, D Max Parkin
Jan 9, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D Max Parkin, Freddie Bray
Apr 24, 2009·Methods of Information in Medicine·Irene Schmidtmann, Maria Blettner
Jul 28, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R M MacKieA M M Eggermont
Apr 24, 2010·Journal of the National Cancer Institute·H Gilbert Welch, William C Black
Oct 13, 2010·Journal of the National Cancer Institute·Donald E HensonArnold M Schwartz
Nov 2, 2011·Journal of the American Academy of Dermatology·Todd V CarteeSuephy C Chen
Jul 5, 2012·The British Journal of Dermatology·A M ForseaA C Geller
Sep 25, 2012·European Journal of Public Health·Monika Hackl, Thomas Waldhoer
Jul 3, 2013·The British Journal of Dermatology·V Nikolaou, A J Stratigos
Aug 22, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·M ArnoldE de Vries
Jan 8, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R ZanettiS Rosso
Jan 9, 2014·International Journal of Environmental Research and Public Health·Daniela HaluzaHanns Moshammer
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
May 10, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jan Willem CoeberghJanny van den Eijnden-van Raaij
Jul 3, 2015·International Journal of Cancer. Journal International Du Cancer·F BrayD Forman
Aug 25, 2015·Journal of the American Academy of Dermatology·Megan M MooreMaryam M Asgari
Oct 1, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Emanuele CrocettiUNKNOWN EUROCARE-5 Working Group:

❮ Previous
Next ❯

Citations

Nov 30, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·P TschandlH A Haenssle
Jan 17, 2019·Wiener medizinische Wochenschrift·Valentin FeichtenschlagerChristian Posch
Sep 4, 2019·Cancer Gene Therapy·Abbas AbiSeyed Mohammad Gheibi Hayat
Oct 11, 2019·Wiener medizinische Wochenschrift·Klemens Rappersberger
Apr 11, 2019·Melanoma Research·Philippe Autier, Jean-François Doré
Mar 7, 2020·The British Journal of Dermatology·K IsakssonJ Lyth
Jan 25, 2020·Journal of the National Cancer Institute·Shirin BajajIman Osman
Feb 6, 2017·Dermatology and Therapy·Zoe ApallaXavier Castellsagué
Jul 25, 2017·Biomedical Optics Express·Esperanza Guerra-RosasAracely Angulo-Molina
May 23, 2018·Dermatology Practical & Conceptual·Wolfgang Weyers
Dec 24, 2019·The Journal of Dermatological Treatment·Abdullah Alyoussef
Dec 16, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Javed IqbalAkhtar Munir
Apr 18, 2021·The British Journal of Dermatology·C DessiniotiA J Stratigos
Aug 6, 2021·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Olga ArchangelidiSiobhán B Carr

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.